MapLight Therapeutics, Inc. (MPLT)
9.82
+0.19
(+1.97%)
USD |
NASDAQ |
Oct 02, 16:00
9.70
-0.12
(-1.22%)
Pre-Market: 08:56
MapLight Therapeutics EPS Diluted (Quarterly) : -1.325 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.325 |
| March 31, 2026 | -1.342 |
| December 31, 2025 | -1.807 |
| September 30, 2025 | -0.6484 |
| June 30, 2025 | -0.7204 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.4924 |
| June 30, 2024 | -0.4441 |
| March 31, 2024 | -0.457 |
| March 31, 2023 | -0.2892 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -0.0464 |
| Cullinan Therapeutics, Inc. | -0.8666 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.19M |
| Total Expenses (Quarterly) | 60.19M |
| Enterprise Value | 143.45M |
| Earnings Yield | -52.16% |
| Normalized Earnings Yield | -52.16 |